ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0813

Investigating TASL, SLC15A4, & TLR7 Associated Risk SNPs in Systemic Lupus Erythematosus

Christina G. Bruxvoort1, Faith A. Porter1, Joshua W. Cavett1, John A. Ice2, Batool Bilal1, R Hal Scofield1 and Valerie M. Lewis1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2OKC Veteran's Affairs Medical Center, Oklahoma City

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, Inflammation, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Abstracts: SLE – Diagnosis, Manifestations, & Outcomes I: Omics

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic inflammatory autoimmune disease that mostly
has it onset among women between the ages 15–44. While the global pathogenic mechanisms that contribute to
SLE remains incompletely known, it is generally accepted that environmental exposures on a genetically
susceptible individual can result in dysregulated innate and adaptive immune responses, eventually leading to the
disease. TASL, TLR7, and SLC15A4 all have SLE associated risk alleles in the form of single nucleotide
polymorphisms (SNPs). Indeed, their protein products coalesce at the endolysosome and play a regulatory role in
the production of Type I interferons (IFNs-I). Upon IFN-I production, inflammation rapidly ensues to promote a
positive feed-forward loop that further signals TASL and TLR7 gene expression. Since TASL, SLC15A4, and
TLR7 appear to work in cooperative manner, we conducted SNP genotyping to assess genetic synergism using
three SLE risk-associated SNPs.

Methods: We obtained genomic DNA from the Oklahoma Lupus Family Repository and Registry (LFRR) for SLE
subects and matched controls (See Table 1). We used the Roche 480 Lightcycler to genotype TASL (rs887369),
SLC15A4 (rs1059312), and TLR7 (rs3853839) using TaqMan probes following the manufacturer’s protocols. We
organized the data based on the presence of homozygous risk SNP, heterozygous risk SNP, or homozygous nonrisk
SNP. Statistics were calculated using GraphPad Prism contingency table format employing Fisher’s exact
test.

Results: We found that African American men had a 7.333% (p=0.0544) odds ratio for the risk allele of rs887369
(TASL). When both the risk alleles for TASL rs887369 and TLR7 rs3853839 SNPs were present in African-
American males, there was an odds ratio of 11.52 (p=0.0132). In the African-American women, there was a
3.959 odds ratio (p=0.0189) when TASL rs887369 and SLC15A4 rs1059312 risk alleles were present.

Conclusion: Our data demonstrate that among African-Americans the risk of SLE was markedly increased by
presence of multiple risk alleles in these genes that are involved in interferon production through the TLR7
pathway. These results suggest a synergistic effect for SLE risk among these genes, at least among African
Americans. The increased prevalence of the disease in this population may be, at least in part, mediated by this
synergistic effect among these risk alleles. Although some European-Americans and Hispanic-Americans had the
risk allele present, it did not affect the SLE risk.

Supporting image 1

OMRF LFRR SLE & Matched Control Subjects

Supporting image 2

African American Male Subjects

Supporting image 3

African American Female Subjects


Disclosures: C. Bruxvoort: None; F. Porter: None; J. Cavett: None; J. Ice: None; B. Bilal: None; R. Scofield: None; V. Lewis: None.

To cite this abstract in AMA style:

Bruxvoort C, Porter F, Cavett J, Ice J, Bilal B, Scofield R, Lewis V. Investigating TASL, SLC15A4, & TLR7 Associated Risk SNPs in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/investigating-tasl-slc15a4-tlr7-associated-risk-snps-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/investigating-tasl-slc15a4-tlr7-associated-risk-snps-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology